Abstract
Introduction

45
Cellular metabolism is an extensively complex network of enzymes, metabolites and other 46 biomolecules required to both maintain homeostasis and appropriately react to stimuli. Biochemists began 47 examining cell metabolism in the mid-19th century, and with our advancement in both experimental 48 techniques and computational capacity, increasing comprehension of metabolic intricacies has been metabolite dynamics nearly inconceivable [1] . Thus, computational modeling reconstruction and simulation 54 of metabolic systems have become pivotal in the analysis and surveillance of such systems. 55 Within the last decade, it has been a considerable goal to develop mathematical models of 56 biological systems that accurately predict cellular and ultimately systems level behavior, providing 57 quantitative details and prediction of phenotypic changes resulting from perturbation. Models as a whole 4 66 modeling approach that gives quantitative information on the interactions, underlying dynamics, and 67 regulation of the components of the system [2] . ODE models operate with the assumption that all reactions 68 occur under evenly mixed, homogenous populations with many molecules in the environment. From early 69 on, ODEs have been used to simulate biochemical kinetics and biochemical networks. This approach, with 70 historically "limited" computational power, was sufficient to describe the interactions and dynamics 71 occurring within biochemical networks. Rapoport et al. describes the ability to determine metabolite 72 concentrations of glycolytic intermediates in erythrocytes by a desktop calculator [3] . In our current time, 73 with the aid of increasing computational power, metabolite concentrations within an enzymatic chain of 74 reactions can be determined almost instantly. There are numerous methods and well defined strategies for 75 solving ODEs; the prevalence and significance in both biochemical simulations in addition to mathematics 76 offer a firm grasp on dealing with simple systems of ordinary differential equations. While ODE modeling 77 reduces computational efforts, the assumptions and simplifications come at the cost of omitting noise and 78 randomization that is inherent in biological systems. Thus, stochastic modeling approaches may be a more 79 realistic representation of in vitro and in vivo systems [2] . 80 Though ODE methods have been well defined in biological community, more recently, systems 81 biology has begun to extend the limits of what has previously been capable computationally; modeling the 82 complexities of biological variation -the stochastic effects inherent in biology. Stochastic models are 83 typically formulated by the chemical master equation (CME), and have the ability to capture the stochastic 84 occurrences common in biological systems. Yet, the drawback comes with the increased mathematical and 85 computational complexity, additionally limiting the size of the network. The CME is a continuous Markov To demonstrate the mechanics of how queueing networks are applied to modeling metabolic (1) [33] .
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To find a method to simulate processes described by the set of ODEs (1) Furthermore, from the perspective of implementing simulation of the metabolic process, it is convenient to 230 ensure that in a given simulation step only one concentration unit of a given metabolite M i is going to be 231 processed. Assuming that there are possible reactions that can be utilizing metabolite M i , the = * -232 probability P i1 that this happens is given by the formula:
and the conditional probability that if just one concentration unit is processed in a particular { |1}
It is important to notice here that metabolomics data often include missing or semi-quantitative data, 242 and some connections between the metabolites might have not been discovered, yet. To account for those 243 unknown or missing reactions, an additional input/output pathway is included in the model for every 244 metabolite considered, and shown in Fig 1 as a dashed For the stochastic simulations presented, the rate equations and model parameters were used as they 287 are indicated in the literature (Table 1 and Table 2 ). Highlighting the significance of the approach, the to 710 depending on the isoform of PFKFB expressed and the tissue type in which it is found. Notably, 327 PFKFB is highly dependent on signaling and hormonal regulation, which can transiently change the K/P 328 ratio given the stimulus. Signaling regulation was not considered in this model, though this component is of 329 interest for further study. Thus, we aimed to keep F26BP relatively constant throughout the initial steady 330 state testing to keep the flux toward a stable level. We found that the K/P ratio of 0.1 kept F26BP and all 331 other metabolites constant over time, the given the parameters used. Therefore, the 0.1 K/P ratio was used 332 to further test the ability of the model to simulate metabolite changes. Simulations were repeated for 30 333 cells, once completed, the average concentrations of each metabolite per cell were graphed as a function of 334 time (Fig 3) . concentrations increased to only 0.18 mM and 0.13 mM (Fig 4) . Again, the aim for the inhibition 419 simulations was to observe the overall trend of metabolite changes, meant for a qualitative comparison. without the need to implement or solve stochastic algorithms. As seen above, GAP and DHAP were 456 represented experimentally as a combination of metabolic intermediates, due to their chemical similarities. 457 Although MS technological methods have become increasingly sensitive to detecting small molecules, 458 isobaric metabolites are often difficult to distinguish from one another. This is the case not only for several 459 metabolic intermediates of glycolysis, but also to additional metabolic pathways. An advantage to the in silico mechanistic modeling of metabolic networks, is the ability to represent such metabolites as individual 461 entities investigating distinct metabolic reactions and the dynamics of each metabolite providing a more in-462 depth observation of the intracellular interactions. 463 The need for models to be informed from and then simulate data using metabolomics sources G6P 0.039 [1] F6P 0.013 [1] F1,6BP 0.00231 [1] F2,6BP 0.004 [3] DHAP 0.02 [2] GAP 0.00194 [2] 1,3BPG 0.000369 [1] 3PG 0.069 [1] 2PG 0.01 [1] PEP 0.017 [1] PYR 0.0586 [1] Intracellular concentrations for each metabolic intermediate. The metabolite concentrations (millimolar) are used in each simulation to initiate the model and are allowed to change over the course of the simulation.
Table 2. Additional Metabolites and Energy Nucleotides
Metabolite Concentration(mM) Reference MgATP 1.52 [1] MgADP 0.11 [1] NAD 0.0599 [1] NADH 0.000245 [1] Pi 1.0 [1] Mg 0.4 [1] ATP 0.159 [1] ADP 0.0937 [1] AMP 0.03 [1] H+ 0.0000721 [2] 2,3BPG 3.1 [1] GSH 3.2 [1] ALA 0.2 [3] G16BP 0.106 [1] Intracellular concentrations required for rate equation calculations. The following metabolites influence the kinetics of the reactions yet were held constant for simulations to directly highlight concentration changes seen in glycolytic intermediates.
